Stocks
Alnylam Pharmaceuticals (ALNY) P/BV US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/BV | ? | 34.1 | -182.8 | -108.4 | 447.7 | 66.0 | 35.4 | ||
| Changes by years, y/y, % | +132% | -635% | -41% | -513% | -85% | +35.0% | |||
Alnylam Pharmaceuticals. P/BV
Alnylam Pharmaceuticals. P/BV, changes, %
Alnylam Pharmaceuticals (ALNY) P/BV US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/BV | ? | 303.3 | 168.7 | 256.3 | 66.6 | 40.9 | 35.4 | |
| Changes by years, y/y, % | -453% | -102% | -77% | -85% | -87% | |||
| Changes by quarters, q/q, % | -33% | -44% | +52% | -74% | -39% | |||
